Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» BMS-986278
BMS-986278
Bristol Myers Squibb eyes phase 3 after pulmonary fibrosis drug reduces lung function decline
Bristol Myers Squibb eyes phase 3 after pulmonary fibrosis drug reduces lung function decline
Fierce Biotech
Bristol Myers Squibb
clinical trials
BMS-986278
idiopathic pulmonary fibrosis
Flag link:
